Cogent Biosciences, Inc. COGT Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s change in other assets?
- Cogent Biosciences, Inc. (COGT) reported change in other assets of $1.84M in Q1 2026.
- How has Cogent Biosciences, Inc.'s change in other assets changed year-over-year?
- Cogent Biosciences, Inc.'s change in other assets increased by 184.5% year-over-year, from -$2.17M to $1.84M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.